Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
AssigneeBoehringer Ingelheim International GmbH
InventorsThomas Friedl, Rolf-Stefan Brickl
Life of this patent
Estimating the term…
Abstract
An extended release pellet comprising an active ingredient selected from pramipexole and the pharmaceutically acceptable salts thereof, and at least one release-modifying excipient.
Claims39
An extended release pellet comprising pramipexole or a pharmaceutically acceptable salt thereof, and at least one release-modifying excipient.
An extended release pellet comprising:
- (1) an inert pellet core;
- (2) a first layer comprising pramipexole or a pharmaceutically acceptable salt thereof;
- and
- (3) a second layer provided on the first layer, the second layer being an extended release coating comprising:
- (a) at least one water-insoluble polymer and optionally a pore former, the resulting pellet having a pH-independent in vitro release characteristic, or
- (b) a mixture of a pH-dependent enteric-coating polymer and a pH-independently water swelling polymer,
- wherein the extended release pellet has a close to zero order in vitro release characteristic at acidic pH values up to pH 6.8, an accelerated release above pH 6.8, and a more accelerated release above pH 7.3.
An extended release pellet comprising pramipexole or a pharmaceutically acceptable salt thereof prepared by wet or melt extrusion or melt granulation using excipients achieving extended release without a further diffusion membrane.
A method of manufacturing extended release pellets, the method comprising the steps of:
- (1) providing an inert starter pellet core;
- (2) applying a solution or dispersion of a first coating composition comprising pramipexole or a pharmaceutically acceptable salt thereof, at least a binder, and optionally excipient(s) onto the inert starter pellet core, wherein the pramipexole or a pharmaceutically acceptable salt thereof is used as unmilled material dissolved/dispersed in a solvent together with the binder(s) and optional excipient(s), and subsequently drying the first coated pellet;
- (3) applying a solution or dispersion of a second coating composition as functional coating composition onto the first coated pellet obtained in step (2), wherein the coating composition comprises (a) at least one water-insoluble polymer and optionally a pore former or (b) a mixture of a pH-dependent enteric-coating polymer and a pH-independently water swelling polymer, and optional excipient(s), and a solvent, and subsequently drying the obtained extended release pellet.
Dependencies are inferred from the claim text.